At Radius,
patients are our everything…
Our Mission
We are a biopharmaceutical company dedicated to transforming the future for underserved, global patient populations in bone health and related therapeutic areas.
We consistently embrace opportunities to improve the lives of our patients, their caregivers, our communities, our partners, and each other.
Living Our Values
It’s extremely important to us that our Mission and Values reflect both what we’re doing for patients and who we are as a team.
Our values were built by our employees. We took their input and feedback, which centered around what we have always believed in – improving the lives of our patients.
Agile
Growth-
Focused
Integrity
Bold
Passionate
Our Journey
As a growth-minded company with an entrepreneurial spirit, we’re always looking for more opportunities to improve the lives of patients.
The focus of our journey so far has been in the bone health space.
2017
We launched our first commercial product in the U.S., TYMLOS® (abaloparatide) injection.
2022
We received supplemental approval from FDA to expand TYMLOS® (abaloparatide) injection.
2023
We expanded our bone health business through the exclusive licensing of U.S. rights to BINOSTO® (alendronate sodium).
2024
Radius is growing and seeking additional partnership opportunities.
Meet Our Leadership Team
We’re proud to introduce our highly experienced leadership team with a proven track record of success commercializing major pharmaceutical brands.
This team brings a diverse range of experience from biotech startups, through to multi-product pharmaceutical companies, and more.
Our leaders are actively involved in the day-to-day running of Radius Health, driving our longer-term strategy forward with an unwavering commitment to the patients we serve and to maintaining a positive culture.
This incredible team and the inspiration that they provide for our growing company is a true differentiator. I feel so fortunate to work with them everyday.
Scott Briggs, CEO